Genetic association studies in primary acquired nasolacrimal duct obstructio

Not Applicable

• Conditions: Chronic dacryocystitisNasolacrimal duct obstruction; NLDO; PANDO; Chronic dacryocystitis; genetic study

• Registration Number: TCTR20180611004
• Lead Sponsor: Ratchadaphiseksomphot Fund

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-06-11
• Study Completion: 2019-02-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

All patients who have chronic dacryocystitis or NLDO or normal population, age 50-70 years, who volunteer to participate in the study

Exclusion Criteria

CNLDO
Lacrimal sac tumor
History of lacrimal drainage system trauma
History of radiotherapy around lacrimal draiange system area

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gene association study 12 months Exome sequencing

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A